339 related articles for article (PubMed ID: 22052885)
1. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
[TBL] [Abstract][Full Text] [Related]
2. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
[TBL] [Abstract][Full Text] [Related]
3. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
[TBL] [Abstract][Full Text] [Related]
4. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
5. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
Yao ZW; Lu X; Shen C; Lin DF
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1339-44. PubMed ID: 24550039
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
7. Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
Jarvis JN; Leeme TB; Molefi M; Chofle AA; Bidwell G; Tsholo K; Tlhako N; Mawoko N; Patel RKK; Tenforde MW; Muthoga C; Bisson GP; Kidola J; Changalucha J; Lawrence D; Jaffar S; Hope W; Molloy SLF; Harrison TS
Clin Infect Dis; 2019 Jan; 68(3):393-401. PubMed ID: 29945252
[TBL] [Abstract][Full Text] [Related]
8. Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis.
Muzoora CK; Kabanda T; Ortu G; Ssentamu J; Hearn P; Mwesigye J; Longley N; Jarvis JN; Jaffar S; Harrison TS
J Infect; 2012 Jan; 64(1):76-81. PubMed ID: 22079502
[TBL] [Abstract][Full Text] [Related]
9. A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
Jackson AT; Nussbaum JC; Phulusa J; Namarika D; Chikasema M; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; van der Horst C; Harrison TS
AIDS; 2012 Jul; 26(11):1363-70. PubMed ID: 22526517
[TBL] [Abstract][Full Text] [Related]
10. Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Zhao T; Xu X; Wu Y; Zhang W; Zeng Q; Lu Y; Yang T; Zhou G; Yu J; Lan K; Harypursat V; Chen Y
BMC Infect Dis; 2022 Aug; 22(1):677. PubMed ID: 35941618
[TBL] [Abstract][Full Text] [Related]
11. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
[TBL] [Abstract][Full Text] [Related]
12. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
[TBL] [Abstract][Full Text] [Related]
13. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
[TBL] [Abstract][Full Text] [Related]
14. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
Liu J; Liu J; Su X; Yang L; Wang Y; Wang A; Xu X; Li M; Jiang Y; Peng F
BMC Neurol; 2022 Jul; 22(1):274. PubMed ID: 35869441
[TBL] [Abstract][Full Text] [Related]
16. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.
Jarvis JN; Meintjes G; Rebe K; Williams GN; Bicanic T; Williams A; Schutz C; Bekker LG; Wood R; Harrison TS
AIDS; 2012 Jun; 26(9):1105-13. PubMed ID: 22421244
[TBL] [Abstract][Full Text] [Related]
18. Combination antifungal therapy for cryptococcal meningitis.
Day JN; Chau TTH; Wolbers M; Mai PP; Dung NT; Mai NH; Phu NH; Nghia HD; Phong ND; Thai CQ; Thai LH; Chuong LV; Sinh DX; Duong VA; Hoang TN; Diep PT; Campbell JI; Sieu TPM; Baker SG; Chau NVV; Hien TT; Lalloo DG; Farrar JJ
N Engl J Med; 2013 Apr; 368(14):1291-1302. PubMed ID: 23550668
[TBL] [Abstract][Full Text] [Related]
19. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials.
Pullen MF; Hullsiek KH; Rhein J; Musubire AK; Tugume L; Nuwagira E; Abassi M; Ssebambulidde K; Mpoza E; Kiggundu R; Akampurira A; Nabeta HW; Schutz C; Evans EE; Rajasingham R; Skipper CP; Pastick KA; Williams DA; Morawski BM; Bangdiwala AS; Meintjes G; Muzoora C; Meya DB; Boulware DR
Clin Infect Dis; 2020 Oct; 71(7):e45-e49. PubMed ID: 31912875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
